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An aqueous extract of the haematophagous poultry ectoparasite, Dermanyssus gallinae, was subfraction-
ated using anion exchange chromatography. Six of these subfractions were used to immunise hens and
the blood from these hens was fed, in vitro, to poultry red mites. Mite mortality following these feeds
was indicative of protective antigens in two of the subfractions, with the risks of mites dying being 3.1
and 3.7 times higher than in the control group (P < 0.001). A combination of two-dimensional
immunoblotting and immunoaffinity chromatography, using IgY from hens immunised with these sub-
fractions, was used in concert with proteomic analyses to identify the strongest immunogenic proteins
in each of these subfractions. Ten of the immunoreactive proteins were selected for assessment as vac-
cine candidates using the following criteria: intensity of immune recognition; likelihood of exposure of
the antigen to the antibodies in a blood meal; proposed function and known vaccine potential of orthol-
ogous molecules. Recombinant versions of each of these 10 proteins were produced in Escherichia coli and
were used to immunise hens. Subsequent in vitro feeding of mites on blood from these birds indicated
that immunisation with Deg-SRP-1 (serpin), Deg-VIT-1 (vitellogenin), Deg-HGP-1 (hemelipoglycopro-
tein) or Deg-PUF-1 (a protein of unknown function) resulted in significantly increased risk of mite death
(1.7–2.8 times higher than in mites fed blood from control hens immunised with adjuvant only,
P < 0.001). The potential for using these antigens in a recombinant vaccine is discussed.
 2015 The Authors. Published by Elsevier Ltd. on behalf of Australian Society for Parasitology Inc. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
The poultry red mite, Dermanyssus gallinae (De Geer, 1778), is
the most commercially important ectoparasite of laying hens glob-
ally. These mites reside in refuges within poultry houses, emerging
at night to feed on the blood of hens (Chauve, 1998). The preva-
lence of the poultry red mite in commercial egg laying premises
is high, with an average of 83% of European facilities affected
(George et al., 2014. The poultry red mite Dermanyssus gallinae:
developing novel management solutions for a complicated and
neglected pest. 10th European Congress of Entomology, 3rd–8th
August, University of York, UK; George et al., 2015). Poultry red
mite is estimated to cost the European poultry industry €130 mil-
lion per annum which is attributed to production loss, higher feed
conversion and control costs (Van Emous, 2005; Sparagano et al.,2009). Severe hen welfare implications are associated with moder-
ate infestation levels (>150,000 mites per hen) and include anae-
mia, an increase in irritation and restlessness, feather-pecking,
cannibalism and hen mortality, although impacts on hen health
can occur at typical infestation levels of 50,000 mites per bird
(Kilpinen et al., 2005). Poultry red mites have also been implicated
as potential reservoirs for a number of commercially important
and zoonotic diseases (Valiente et al., 2009; Brannstrom et al.,
2010) and can feed adventitiously on mammals, including humans
(George et al., 2015).
Acaricidal treatments may give only limited or short-lived
reductions in mite numbers in commercial hen houses due to both
the difficulties associated with effective application and the emer-
gence of acaricide resistance (Marangi et al., 2009; Sparagano et al.,
2014). In spite of these issues, chemical control of poultry red
mites through the use of synthetic acaricides remains the domi-
nant method in commercial premises. A recent surge in research
activity for novel methods of controlling poultry red mites has
encompassed novel biopesticides and plant-derived products,
semiochemicals and growth regulators, vaccines, biological
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management solutions (recently comprehensively reviewed by
Sparagano et al., 2014).
Vaccination against blood-feeding ectoparasites can result in
effective and sustainable control (De la Fuente and Kocan, 2003;
Willadsen, 2004) and offers advantages including prolonged effi-
cacy, freedom from chemical residues/environmental pollution
and reduced risk of resistance. In previous studies, we and others
(Harrington et al., 2009), showed that vaccination of hens is a fea-
sible strategy to control poultry red mite (Bartley et al., 2009, 2012;
Harrington et al., 2009; Wright et al., 2009) and the identification
of suitable antigens for vaccine production is now a principal goal
of research in this area.
To date, pragmatic approaches of fractionating native protein
extracts of the mites (Wright et al., 2009) or rational approaches
for selecting suitable recombinant D. gallinae antigens based on
function and/or orthology (Bartley et al., 2009, 2012) have been
used to identify effective autogenous vaccine preparations and
recombinant vaccine candidate antigens, respectively. We previ-
ously showed that fractionation of D. gallinae extracts into soluble,
membrane-associated, membrane-bound and insoluble material
enriched protective antigens in the soluble fraction (Wright et al.,
2009). This soluble mite extract (SME) is a complex mixture of
macromolecules so, in the work described herein, we have taken
a combined pragmatic and rational approach in order to identify
the immunoreactive components of SME, prioritise their analysis
as suitable vaccine antigens in an order of merit, express them as
recombinant proteins and test their vaccine efficacy in vitro.2. Materials and methods
2.1. Collection and conditioning of D. gallinae
Mixed stage and gender D. gallinae mites were collected into
75 cm2 vented tissue culture flasks (Corning, USA) from a commer-
cial egg production unit in Scotland, UK. Mites that were snap fro-
zen in liquid nitrogen within 24 h of collection constituted the
‘‘fed” mite population. ‘‘Starved” mites were conditioned by initial
incubation at room temperature (RT) for 7 days, followed by stor-
age at 4 C for 14 days (modified from McDevitt et al., 2006).
Starved mites were either used in in vitro mite feeding assays or
were snap frozen in liquid nitrogen. All snap-frozen mites were
stored at 80 C until required.
2.2. Preparation of SME
Aqueous-soluble proteins were extracted from snap-frozen
mites as follows: 1 g of frozen mites was suspended in 10 ml of
ice-cold PBS and homogenised, on ice, for two 30 s pulses (Ultra
Turrex T 25 D-S2 with a S25N-8G dispersing element (IKA-
Werke GmbH & Co. KG, Germany). Insoluble material and debris
were removed by centrifugation at 25,000g for 20 min at 4 C.
The soluble material was decanted and centrifuged for a second
time. The resulting SME was immediately snap-frozen in liquid
nitrogen and stored at 80 C. The concentration of proteins in
each SME was measured using a PierceTM bicinchoninic acid (BCA)
protein assay kit (Thermo Fisher Scientific, USA), following the
manufacturer’s protocol.
2.3. Ion-exchange chromatography (IEX) of SME and pooling of IEX-
fractions for use as immunogens
SME from fed and starved mites was desalted using PD-10 col-
umns (GE Healthcare, UK) and eluted in 20 mM Tris–HCl, pH 7.4.
IEX was performed at RT using HiTRAP Q HP anion columns (GEhealthcare) in conjunction with an ÄKTA fast liquid protein chro-
matography system (GE Healthcare) eluting with a linear gradient
of 0–0.5 M NaCl in 20 mM Tris–HCl, pH 7.4, followed by an iso-
cratic step (20 mM Tris–HCl, 1 M NaCl, pH 7.4). Eluted proteins
were analysed by electrophoresis using 12% Bis–Tris Novex gels
in NuPAGE MES SDS Running Buffer (GE Healthcare). Proteins
were either visualised by silver staining (SilverQuestTM Silver Stain-
ing Kit, Thermo Fisher Scientific) or transferred to a nitrocellulose
membrane using an Xcell II blot module (GE Healthcare), following
the manufacturer’s procedures. Western blotting was performed as
described previously (Bartley et al., 2009). Briefly, blots were incu-
bated in 5% Marvel in PBST (PBS, 0.05% Tween 20 (Sigma, USA)).
After washing three times in PBST, the immobilised proteins were
probed with yolk-derived IgY (yolk-IgY, purified using the PierceTM
Chicken IgY Purification Kit, Thermo Fisher Scientific) in PBS
(100 lg/ml) from hens that had been immunised with SME. Blots
were washed and bound IgY was detected by incubating in
rabbit-anti-IgY-peroxidase conjugate (diluted at 1:20,000 in PBS,
Sigma). Blots were washed five times in PBST prior to developing
in SuperSignalTM West Pico Chemiluminescent Substrate (Thermo
Fisher Scientific). Blot images were captured using an ImageQuant
LAS4000 luminescent image analyzer (GE Healthcare). IEX frac-
tions were thus pooled into five groups (henceforth referred as
IEX group 1 to IEX group 5) based on their immunogenic profiles.
Each of the five IEX groups and unfractionated SME were concen-
trated using Ultracel-10K Amicon Ultra-15 centrifugal filter
units (Merck Millipore Ltd, Germany), filter sterilised through a
0.22 lMMillex-GV 13 mm polyvinyl difluoride (PVDF) unit (Merck
Millipore Ltd) and their concentration determined (PierceTM BCA
protein assay) prior to immunisation of hens (see Section 2.8).
2.4. Two-dimensional gel electrophoresis (2-DGE) and identification of
immunoreactive spots
IEX group 1 and IEX group 4 proteins were precipitated, then
solubilised in 7 M urea, 2% CHAPS, 2 M thiourea, 0.3% DTT,
0.002% bromophenol blue, 2% immobilised pH gradient (IPG) buf-
fer (IPG buffer 7–11 for IEX group 1; 3–10 for IEX group 4), rehy-
drated on the appropriate Immobiline DryStrips for 16 h at RT
and subjected to isoelectric focusing using an EttanTM IPGphorTM unit
(GE Healthcare). The focussed proteins were denatured in equili-
bration buffer (50 mM Tris–HCl pH 8.8, 6 M urea, 30% glycerol,
2% SDS, 0.002% bromophenol blue) supplemented with 10 mg/ml
of DTT for 15 min at RT, followed by incubation for 15 min at RT
in equilibration buffer containing 25 mg/ml of iodoacetamide, then
separated in the second dimension using ExcelGelTM 2-D homoge-
nous 12.5% (25 cm  11 cm) gels in a MultiphorTM II Electrophoresis
System (GE Healthcare). One replicate of the second dimension
gels was stained with SimplyBlueTM SafeStain (Thermo Fisher Scien-
tific) and a further two replicate gels were electroblotted onto
Hybond-C nitrocellulose membranes (Thermo Fisher Scientific)
and immunoscreened as described above with yolk-IgY from hens
that had been immunised with the IEX group 1 or IEX group 4 pro-
teins (positives) or yolk-IgY from the adjuvant-only control hens
(group 7 controls). Co-localised stained and immunolabelled pro-
tein spots were excised from the SimplyBlueTM-stained gel and
the proteins identified as described in Section 2.6.
2.5. Immunoaffinity enrichment of SME proteins
Yolk-IgY, derived from hens immunised with IEX group 4 pro-
teins, was cross-linked to a 1 ml HiTrap NHS-activated HP column
following the manufacturer’s instructions (GE Healthcare). Follow-
ing equilibration, 1.4 mg of IEX group 4 proteins were circulated
through the column for 16 h at 4 C. Unbound material was
washed from the column with 10 ml of PBS and bound protein
Table 1
Summary of the 10 candidate vaccine antigens selected from Dermanyssus gallinae
following a fractionation and immunogenicity analysis of soluble mite extract.
Candidate
antigen
Contig
sequence
Predicted functiona GenBank accession
numberb
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prior to electrophoresis using a 12% Bis–Tris Novex gel in NuPAGE
MES SDS Running Buffer (GE Healthcare), staining with Sim-
plyBlueTM SafeStain and protein identification as described in
Section 2.6.Deg-PUF-2
variant 1
13089 Protein of unknown
function
KR697570
Deg-PUF-2
variant 2
13089 Protein of unknown
function
KR697571
Deg-ASP-1 00293 Aspartyl
proteinase/cathepsin D
KR697569
Deg-GPD-1 00877 Phosphoglycerate
dehydrogenase
KR697574
Deg-SRP-1 02564 Serpin KR697565
Deg-PUF-1 11549 Protein of unknown
function
KR697568
Deg-HGP-1
N-term
13207 Hemelipoglycoprotein KR697566
Deg-HGP-1
C-term
13207 Hemelipoglycoprotein KR697566
Deg-VIT-1 N-
term
12013 Vitellogenin KR697567
Deg-PUF-3 00186 Protein of unknown
function
KR697575
Deg-SRP-2 01514 Serpin KR697572
Deg-CPR-1 13094 Peptidase C1A-like
cysteine proteinase
KR697573
a Based on homology searching.
b Accession numbers of the 10 vaccine candidate DNA sequences deposited in
GenBank.2.6. Protein identification using liquid chromatography–electrospray
ionisation–tandem mass spectrometry (LC–ESI–MS/MS)
Protein spots were picked manually from second dimension
SDS–PAGE gels (IEX group 1 and IEX group 4 proteins) using a One-
Touch 2D gel spotpickerTM (The Gel Company, USA) and gel lanes
resulting from the immunoaffinity enrichment of IEX group 4 pro-
teins were sliced horizontally from top to bottom to yield a series
of 24 equal gel slices. Gel slices and excised spots were then sub-
jected to standard in-gel destaining, reduction, alkylation and
trypsinolysis procedures (Shevchenko et al., 1996). Digests were
subjected to liquid chromatography–electrospray ionisation–tan-
dem mass spectrometry (LC–ESI–MS/MS) analysis employing an
DionexTM Ultimate 3000 nano-HPLC system (Thermo Fisher Scien-
tific) comprising a WPS-3000 well-plate micro auto sampler, a
FLM-3000 flow manager and column compartment, a UVD-3000
UV detector, an LPG-3600 dual-gradient micropump and an SRD-
3600 solvent rack controlled by ChromeleonTM chromatography
software (Thermo Fisher Scientific). A micro-pump flow rate of
246 ll/min1 was used in combination with a cap-flow splitter car-
tridge, affording a 1/82 flow split and a final flow rate of 3 ll/min
through a 5 cm  200 lm internal diameter PepSwiftTM monolithic
reversed phase column (Thermo Fisher Scientific) maintained at
50 C. Samples of 4 ll were applied to the column by direct injec-
tion and bound peptides eluted by the application of a 15 min lin-
ear gradient from 8% to 45% solvent B (80% acetonitrile, 0.1% formic
acid) and directed through a 3 nl UV detector flow cell. Liquid chro-
matography (LC) was interfaced directly with a 3-D high capacity
ion trap amaZon-ETD mass spectrometer (Bruker Daltonics, USA)
via a low volume (50 ll/min maximum) stainless steel nebuliser
(Agilent Technologies, USA; Cat. No. G1946-20260) and electro-
spray ionisation (ESI). Parameters for tandem MS analysis were
based on those described previously (Batycka et al., 2006). Decon-
voluted MS/MS data in Mascot Generic Format (.mgf) were
imported into ProteinScapeTM V3.1 (Bruker Daltonics) for down-
stream database mining of an National Center for Biotechnology
Information (NCBI), USA non-redundant (nr) database (09-Jan-
2015 release) and a custom D. gallinae transcriptomic database
(Bartley et al., 2015, unpublished data) to identify DNA sequences
encoding the respective proteins using stringent identification cri-
teria (as described in Taylor and Goodlett, 2005; Nisbet et al., 2010)
utilising the MascotTM V2.3 (Matrix Science, UK) search algorithm.2.7. Expression and purification of recombinant vaccine candidate
proteins
The complete coding sequences (CDS) for the open reading
frames (ORFs) of the 10 selected vaccine candidates (summarised
in Table 1) were confirmed by direct PCR amplification of the com-
plete ORFs from cDNA or were determined by rapid amplification
of cDNA ends (RACE) using the SMARTTM RACE cDNA amplification
kit (Takara Bio Europe/SAS, France). Amplifications were per-
formed according to the manufacturer’s recommended conditions
(the primer sequences and amplification conditions are available
upon request), the products were cloned into a pGEM T-Easy plas-
mid vector (Promega, USA) and the DNA sequences obtained (Euro-
fins Genomics, Germany).
With the exception of D. gallinae protein of unknown function
(Deg-PUF)-2 (Deg-PUF-2) variants 1 and 2, the CDS for each vac-cine candidate was subcloned into the InvitrogenTM pET SUMO
expression vector (Thermo Fisher Scientific) or into Novagen
pET22b (Merck Millipore Ltd), omitting the ORF-encoded signal
peptide sequence where appropriate. Due to its large size, D. galli-
nae hemelipoglycoprotein-1 (Deg-HGP-1) was cloned and
expressed in two sections (N- and C-terminal portions, encoded
by nucleotide bases 139–3179 and 3160–4728, respectively) and
only the N-terminal portion of D. gallinae vitellogenin-1 (Deg-
VIT-1) (encoded by nucleotide bases 43–3157) was expressed.
The CDS for both variants of the sequence encoding Deg-PUF-2
were codon optimised for prokaryotic expression and synthesized
(Eurofins Genomics) before subcloning into the pET22b vector. Fol-
lowing transformation of each of the plasmids into Escherichia coli
BL21-RIPL competent cells (Agilent Technologies), recombinant
versions of each vaccine candidate protein were expressed and
affinity-purified using His-TrapTM HP columns (GE Healthcare). Der-
manyssus gallinae phosphoglycerate dehydrogenase-1 (Deg-GPD-
1), D. gallinae serpin-1 (Deg-SRP-1), Deg-PUF-1 and Deg-PUF-3
were recovered from the soluble fraction of lysed E. coli in binding
buffer, whereas Deg-PUF-2 variants 1 and 2, Deg-HGP-1, Deg-VIT-
1, D. gallinae aspartyl proteinase-1 (Deg-ASP-1), Deg-SRP-2 and D.
gallinae Peptidase C1A-like cysteine proteinase-1 (Deg-CPR-1)
were recovered from inclusion bodies after solubilisation in 8 M
urea. Proteins in 8 M urea were re-folded by sequential dialysis
against refolding buffer (100 mM Tris–HCl, pH 8.0; 0.4 M L-
Arginine; 2 mM EDTA; 0.5 mM oxidative glutathione; 5 mM
reduced glutathione) with decreasing concentrations of urea (6,
4, 2 and 1 M urea), followed by dialysis against 10 mM Tris–HCl;
0.5 M NaCl, pH 7.4 for 16 h at 4 C.
2.8. Immunisation of hens and the evaluation of acaricidal effects
All experiments using hens were conducted under the regula-
tions of a UK Home Office Project Licence; experimental design
was ratified by the Experiments and Ethics Committee of the More-
dun Research Institute (MRI), UK. Two separate hen immunisation
experiments were performed. In experiment 1, 14 ISA-Warrens
hens, 24 weeks old, were randomly assigned into seven groups
Table 2
Mortality of Dermanyssus gallinae following ingestion of blood from hens immunised with pooled ion-exchange chromatography fractions (IEX groups 1–5) of soluble mite extract
(SME). Hens immunised with SME or adjuvant only served as controls.
Group Antigen Cox’s proportional hazard model Generalised linear mixed model
Hazard ratio a LCL UCL P valuec Mean mortalityb LCL UCL P valuec
1 IEX-group-1 3.06 2.08 4.52 <0.001 0.37 0.20 0.57 0.006
2 IEX-group-2 1.21 0.78 1.89 0.400 0.16 0.08 0.31 0.696
3 IEX-group-3 2.31 1.51 3.54 <0.001 0.30 0.15 0.50 0.041
4 IEX-group-4 3.72 2.51 5.51 <0.001 0.40 0.22 0.61 0.003
5 IEX-group-5 2.52 1.70 3.72 <0.001 0.30 0.16 0.50 0.034
6 Whole SME 2.42 1.63 3.60 <0.001 0.35 0.19 0.55 0.012
7 Adjuvant only – – – – 0.14 0.06 0.27 –
LCL, lower 95% confidence level; UCL, upper 95% confidence level.
a The risks of mites dying at any time during the 96 h post feeding (hazard ratio), compared with the adjuvant only control group, were analysed using Cox’s proportional
hazard model.
b The mean mortality rates of mites at 96 h post feeding in comparison with the adjuvant control group were analysed using a generalised linear mixed model.
c P values show the statistical significance of a group compared with the adjuvant only control (group 7).
Table 3
Mortality of Dermanyssus gallinae following ingestion of blood from hens vaccinated with recombinant poultry red mite antigens.
Group Antigen Cox’s proportional hazard model Generalised linear mixed model (24 h post
feeding)
Generalised linear mixed model (96 h post
feeding)
Hazard ratioa LCL UCL P valuec Mean mortalityb LCL UCL P valuec Mean mortalityb LCL UCL P valuec
Tranche 1
1 Deg-PUF-2 1.10 0.73 1.67 0.650 0.11 0.05 0.23 0.823 0.14 0.07 0.26 0.760
2 Deg-ASP-1 0.89 0.60 1.33 0.570 0.10 0.05 0.21 0.624 0.13 0.07 0.24 0.971
3 Deg-GPD-1 1.21 0.79 1.84 0.380 0.13 0.06 0.26 0.884 0.16 0.08 0.29 0.514
4 Deg-SRP-1 2.09 1.48 2.94 <0.001 0.24 0.12 0.41 0.038 0.25 0.14 0.41 0.011
5 Deg-PUF-1 2.79 2.01 3.88 <0.001 0.29 0.16 0.48 0.005 0.31 0.18 0.48 0.001
6 Adjuvant only – – 0.12 0.06 0.24 – 0.13 0.07 0.24 –
Tranche 2
7 Deg-HGP-1 1.66 1.35 2.03 <0.001 0.47 0.33 0.61 0.052 0.48 0.35 0.62 0.049
8 Deg-VIT-1 2.03 1.66 2.48 <0.001 0.50 0.37 0.64 0.021 0.52 0.38 0.66 0.020
9 Deg-PUF-3 1.01 0.80 1.28 0.930 0.30 0.20 0.44 0.800 0.33 0.21 0.47 0.698
10 Deg-SRP-2 0.82 0.64 1.05 0.120 0.20 0.12 0.31 0.265 0.22 0.13 0.34 0.365
11 Deg-CPR-1 1.89 1.53 2.34 <0.001 0.43 0.30 0.58 0.117 0.45 0.32 0.60 0.094
12 Adjuvant only – – – – 0.28 0.18 0.41 – 0.29 0.19 0.42 –
LCL, lower 95% confidence level; UCL, upper 95% confidence level.
a The risks of mites dying at any time during the 96 h post feeding (hazard ratio), compared with the adjuvant only control groups, were analysed using Cox’s proportional
hazard model.
b The mean mortality rates of mites at 24 and 96 h post feeding, in comparison with the adjuvant control group, were analysed using a generalised linear mixed model.
c P values show the statistical significance of a group compared with the adjuvant only control groups (groups 6 and 12).
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the five IEX groups of proteins (see Section 2.3), unfractionated
SME (group 6) or adjuvant only (group 7) (with treatments sum-
marised in Table 2). Each 200 ll immunisation contained 200 lg
of the appropriate antigen (groups 1–6) and 200 lg of QuilA adju-
vant (Brenntag Biosector, Denmark) (all groups). Experiment 2 was
performed in two tranches: in each tranche, 12 ISA-Warrens hens,
aged 16 weeks old (tranche 1) and 12 ISA-Warrens hens, aged
21 weeks old (tranche 2), were randomly assigned to six groups
and immunised three times, at 2 week intervals, with 50 lg of
recombinant vaccine antigen (see Section 2.7), as described in
Table 3, formulated with 200 lg of QuilA as adjuvant. An
adjuvant-only control group was also included with each tranche.
In both experiments, vaccines were administered i.m. into alter-
nate breast muscle. Eggs were collected prior to vaccination and
throughout the study as a source of yolk-IgY. Whole blood was
withdrawn from the brachial wing vein prior to vaccination, at
each vaccination and at three time points following the final vacci-
nation: 3, 5 and 6 weeks post vaccination in experiment 1, and 2, 3
and 4 weeks post vaccination in experiment 2. Blood was with-
drawn into heparinised tubes (final concentration 36 United States
Pharmacopoeia units (USP)/ml blood). Serumwas recovered from a
subsample of heparinised blood for immunological evaluation and
antigen-specific IgY levels throughout the experiment were moni-
tored by ELISA. In order to assess the effect of blood ingestion fromvaccinated hens on mite survival, equal volumes of whole hep-
arinised blood were pooled from the two birds in each group and
fed to starved mites using a modified version of the in vitro feeding
apparatus described by Wright et al. (2009) (Fig. 1). Ten feeding
chambers were set up for each group and the mites were allowed
feed for a 24 h period at 39 C, 75% relative humidity. Mites were
removed from the 10 feeding chambers and individual fed mites
were isolated in single wells of a 96-well microtitre plate, where
they were immediately scored for mortality and again at 48, 72
and 96 h post feeding. The feeding assays were replicated with
blood taken on three separate occasions following the final vacci-
nation and involving a minimum number of 326 fed mites on each
occasion.
2.9. Statistical analyses
Mite mortality data from experiment 1 and the two tranches of
experiment 2 were all analysed separately using two different
approaches for each of the three data sets. A survival analysis,
incorporating the treatment group as a fixed effect, was conducted
based on Cox’s proportional hazards model (PHM) with frailty
function. Mites that survived after 96 h were treated as censored
data. The frailty function considered the replicate (the three blood
sampling occasions for each bird pair) within each experiment as a
random effect, and the estimate of this random effect was obtained
* 
* 
* 
* 
* 
* 
* 
* 
* 
* 
Blood meal/parafilm interface 
Modified pastette bulb 
Castration ring 
5ml  cut-down cryotube 
Filter paper ring 
Cryotube cap 
Mites* 
Heparinised bloodmeal 
Filter paper wick 
Fig. 1. An in vitro feeding device for Dermanyssus gallinae. The device is a
modification of that described by Wright et al. (2009). Specific modifications
include: the replacement of a chick-skin feeding membrane with pre-stretched
Parafilm‘‘M” (Bemis Flexible packaging, USA) and the placement of a lamb rubber
castration ring (NetTex, UK) around the pastette bulb to create a tight seal to
prevent blood-meal leakage. A ring of filter paper was placed around the internal
circumference of the tube near the feeding membrane, together with a filter paper
wick, to soak up blood in the event of feeding membrane failure. Mites are indicated
as ⁄.
K. Bartley et al. / International Journal for Parasitology 45 (2015) 819–830 823using the restricted maximum likelihood method, assuming a
Gaussian distribution. The hazard ratio (the ratio of the instanta-
neous risk of mites dying at any time in the experiment, which is
assumed to be constant at all times in Cox’s PHM) was used to
compare the different antigens with the adjuvant. In the second
approach, the cumulative mortality rates of mites in each treat-
ment group at 24, 48, 72 and 96 h were analysed with a separate
generalised linear mixed model (GLMM) at each time point, using
a binomial distribution and logit link function, to examine the
mean mortality rates compared with that of the adjuvant only
groups at those time points. These models included the treatment
group as a fixed effect and the feeding assay as a random effect,
and observation level data were used to estimate the over-
dispersion in the data. All statistical analyses were carried out188
98 
62
49
38
28
17
14
KDa
FT
 
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23A 
Fig. 2. The separation of Dermanyssus gallinae soluble mite extract using ion exchange ch
exchange column (GE Healthcare) and eluted with an increasing NaCl gradient. (A) PA
fractions (1–25) obtained from the ion exchange chromatography of soluble mite extra
Healthcare) and silver stained (SilverQuest, Thermo Fisher Scientific). (B) Chromatograms
from fed mites (solid line) and starved mites (dotted line) soluble mite extract. The figur
(FT, 0–10 ml) and the 25 sequentially eluted 1 ml fractions (10–35 ml). The broken grey l
on the secondary Y axis (NaCl).using R software version 3.1.0 with appropriate R packages (stats,
lme4, survival, frailtypack, ggplot2; http://www.R-project.org).
P < 0.05 was deemed statistically significant.3. Results
3.1. IEX of SME and pooling of IEX fractions for use as immunogens
IEX was used to separate the complex mix of protein contained
in the SME into a 10 ml flow-through (FT) fraction containing
unbound proteins and 25 sequentially eluted 1 ml fractions
(Fig. 2). The abundant 14 kDa band present in the FT fraction
and, to a lesser extent, in all fed mite eluates (Fig. 2A) was identi-
fied by MALDI-ToF-MS analysis as hen haemoglobin subunits. In
starved mites, the amplitude of the respective FT peak was reduced
approximately 11-fold compared with the fed-mite FT fraction
(Fig. 2B), indicating that starvation conditioning of mites was suc-
cessful in reducing host haemoglobin contamination in the SME. A
duplicate gel to that shown in Fig. 2A, was electroblotted onto
nitrocellulose and probed with yolk-IgY generated in hens that
had been immunised with whole SME (Supplementary Fig. S1).
Based upon the immunoreactive profiles, adjacent fractions from
the IEX separation were pooled together into five groups. Western
blotting of these IEX groups and unfractionated SME (Fig. 3)
demonstrated that there was minimal overlap in immunoreactivity
between IEX groups and that specific proteins were enriched in the
IEX groups compared with the SME. Minimal immunoreactivity
was detected in the IEX groups and SME when screened with con-
trol IgY (from a hen that had not been immunised with mite
extracts), except for two bands which corresponded in size with
IgY light and heavy chains. The IgY present in the IEX groups and
SME was derived from the blood meal present in the guts of mites
and was bound by the anti-IgY-peroxidase conjugate.
3.2. Generation of IgY responses to IEX groups and their effects on mite
mortality
Following immunisation of hens with the five IEX groups or
unfractionated SME (group 6), antigen-specific IgY levels peaked
at 2 weeks post final vaccination (Supplementary Fig. S2) and did
not diminish during the following 4 weeks (Supplementary
Fig. S3). The immunoreactive profiles differed markedly between
groups, indicating that the strategy used to pool the IEX fractions0
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romatography. Soluble mite extract was separated using a 1 ml HiTRAP Q HP anion
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of the ion exchange chromatography elution profiles of soluble mite extract derived
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Fig. 3. Immunoreactive profiles of soluble mite extract of Dermanyssus gallinae
separated by ion exchange chromatography. Ion exchange chromatography
fractions were pooled into five groups (IEX groups 1–5), with IEX group 1 consisting
of the column flow-through (FT) and IEX groups 2–5 of selectively pooled eluted
fractions. Twomicrogram of IEX groups 1–5 (lanes 1–5) and 2 lg of the soluble mite
extract (SME, lane 6) were separated on a 12% Bis–Tris Novex gel (GE Healthcare),
transferred to nitrocellulose and probed with IgY generated against the soluble mite
extract (A) or IgY from a hen that had not been injected with soluble mite extract
(B). Bound IgY was detected with rabbit anti-IgY-peroxidase (Sigma) and visualised
with SIGMA FASTTM 3,30-diaminobenzidine substrate (Sigma).
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stituents of the IEX groups. To assess the effect on mite survival
after feeding, whole heparinised blood from hens immunised with
IEX groups 1–5 or with unfractionated SME was fed to starved
mites using the in vitro feeding device on three separate occasions
at weeks 3, 5 and 6 post final vaccination. A statistically significant
(P < 0.001) reduction in the mean survival proportions of mites fed
on the blood from hens immunised with SME and the IEX groups,
except IEX group 2, was observed when compared with mites fed
on blood from hens in the adjuvant-only control group (group 7)
(Fig. 4, results summarised in Table 2). Mites fed on the blood from0.7 
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Fig. 4. The observed mean survival proportions of Dermanyssus gallinae following the i
fractions (IEX groups). Mites were fed with whole heparinised blood from hens immun
adjuvant only (Control group 7). The mean proportions of surviving mites at 24, 48, 72
frailty function and the corresponding 95% confidence intervals (shaded), are plotted.hens immunised with IEX groups 1 and 4 had the highest risk of
dying during the 96 h following feeding and were 3.06 (95% confi-
dence interval (CI): 2.08, 4.52) and 3.72 (95% CI: 2.51, 5.51) times
more likely to die than mites in the control group (P < 0.001).
GLMM analysis of the cumulative mortality rates of mites fed on
blood from immunised hens at 96 h post feeding (Table 2) also
identified IEX groups 1 and 4 treatments as producing the highest
mite mortality rates at 0.37 (95% CI: 0.20, 0.57) and 0.40 (95% CI:
0.22, 0.61), respectively, and these estimates were significantly
(P < 0.004) different from the mean mortality of mites fed on the
control group blood (0.14, 95% CI: 0.06, 0.27) at that time point.
At the earlier time points of 24, 48 and 72 h post feeding, only
mites fed on the blood from hens immunised with IEX groups 1
and 4 showed a consistent and statistically significant (P < 0.030)
increase in mortality compared with those fed on blood from the
adjuvant-only control group.
3.3. Identification and selection of vaccine candidates using 2-DGE
immunoblot and immunoaffinity enrichment
Two complementary approaches, immunoaffinity purification
and 2-DGE/immunoblotting, were used to identify the immunore-
active proteins within the IEX groups 1 and 4. Subsequently, pro-
tein identification was facilitated by LC–ESI–MS/MS and using
the resulting spectral data to mine an annotated red mite tran-
scriptome and the NCBI nr database. The immunoreactive proteins
identified from IEX groups 1 and 4 are summarised in Tables 4 and
5, respectively. Full details are available in Supplementary
Table S1. The 2-D gel and immunoblot profiles of IEX groups 1
and 4 are shown in Fig. 5. Due to a high abundance of contaminat-
ing host haemoglobin amongst the fed mite-derived proteins com-
prising IEX group 1, the corresponding FT fraction derived from IEX
of starved mite SME was used preferentially for these analyses. In
total, 15 individual immunoreactive proteins were identified by 2-
DGE/immunoblotting of IEX group 1 (Table 4), and immunoaffinity
purification of this group of proteins did not identify any further
immunoreactive proteins (not shown). Immunoaffinity purifica-
tion and 2-DGE/immunoblotting of IEX group 4 material identified6 0 48 72 96 24 
(h) 
IEX group 3 IEX group 4 
Control group 7 
ngestion of blood from hens immunised with pooled ion exchange chromatograph
ised with IEX groups 1–5 (IEX groups 1–5), soluble mite extract (IEX group 6) or
and 96 h post-feeding were calculated using Cox’s proportional hazard model with
Table 4
Identification of Dermanyssus gallinae proteins present in IgY-immunoreactive spots on a two-dimensional gel immunoblot of the soluble mite extract fractionated by ion
exchange chromatography (IEX group 1). Those contigs selected for evaluation as vaccine candidates are given in bold.
D. gallinae contig
number
Top BLASTx hit description and (species) NCBI accession of top
BLASTx hit
%
identity
E value Bit
score
contig00186 PREDICTED: uncharacterized protein LOC100902161 (Metaseiulus occidentalis) XP_003741885.1 60.8 3.09E53 213.4
contig00610 PREDICTED: fumarate hydratase, mitochondrial-like (Metaseiulus occidentalis) XP_003742734.1 94.3 1.65E70 270.8
contig00877 D-3-phosphoglycerate dehydrogenase, putative (Ixodes scapularis) XP_002404432.1 69.2 2.66E126 458.8
contig01284 PREDICTED: inositol-3-phosphate synthase 1-A-like (Metaseiulus occidentalis) XP_003740765.1 81.5 5.43E42 148.3
contig01514 PREDICTED: serpin B9-like (Metaseiulus occidentalis) XP_003744662.1 36.4 0.00025 41.2
contig01816 PREDICTED: aconitate hydratase, mitochondrial-like (Metaseiulus occidentalis) XP_003744180.1 94.0 0 544.7
contig01795 PREDICTED: uncharacterized protein LOC100902161 (Metaseiulus occidentalis) XP_003741885.1 56.1 2.93E113 415.2
contig02564 PREDICTED: serpin B9-like (Metaseiulus occidentalis) XP_003737604.1 48.3 0 544.7
contig02962 Bifunctional purine biosynthesis protein (Aedes aegypti) XP_001662952.1 75.7 1.72E61 142.5
contig03245 PREDICTED: putative phospholipase B-like 2-like (Metaseiulus occidentalis) XP_003746012.1 57.4 0 276.9
contig04330 PREDICTED: inositol-3-phosphate synthase 1-A-like (Metaseiulus occidentalis) XP_003740765.1 78.7 4.51E178 631.7
contig05061 PREDICTED: delta-1-pyrroline-5-carboxylate dehydrogenase, mitochondrial-like
(Metaseiulus occidentalis)
XP_003745491.1 65.3 1.30E35 154.8
contig07527 PREDICTED: fumarate hydratase, mitochondrial-like (Metaseiulus occidentalis) XP_003742734.1 80.5 1.53E39 167.9
contig11549 PREDICTED: uncharacterized protein LOC100908877 (Metaseiulus occidentalis) XP_003744327.1 34.3 2.33E08 64.3
contig12646 PREDICTED: aconitate hydratase, mitochondrial-like (Metaseiulus occidentalis) XP_003744180.1 86.2 5.00E66 256.1
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shown in Fig. 6 shows IEX group 4-derived proteins, pre- and post-
affinity enrichment (Fig. 6A, lanes 3 and 4, respectively), probed
with sera collected from hens immunised with IEX group 4 and
demonstrated substantial enrichment of immunoreactive proteins
following immunoaffinity purification, particularly of proteins
with molecular weights P55 kDa.
A selection of 10 vaccine candidates was made from the 50 con-
tig sequences identified in IEX groups 1 and 4, based on their pre-
dicted functions (inferred from the BLASTx hit annotation). Contigs
with a high identity against avian host proteins or predicted to
encode for proteins deemed inaccessible to the immune response
(e.g. mitochondrial) were immediately eliminated from the selec-
tion. Contigs with predicted functions likely to be necessary for
the survival of the mite (e.g. feeding, digestion, detoxification or
reproduction) or those contigs that exhibited a high level of
immunoreactivity, with or without associated gene annotation,
were retained.
3.4. Production of recombinant versions of the vaccine candidates
The complete CDS of nine selected antigens and partial coding
sequences of two variants of Deg-PUF-2 were obtained using RACE,
PCR and DNA sequencing (accession numbers are listed in Table 1).
Recombinant, full-length, hexa histidine (6xHis)-tagged versions of
seven of the 10 vaccine candidate proteins (minus signal peptides
where appropriate) were expressed and purified by nickel-affinity
chromatography. The two Deg-PUF-2 variants 1 and 2 were pro-
duced as recombinant 6xHis-tagged proteins with C-terminal trun-
cations. Deg-HGP-1 and Deg-VIT-1 were predicted, from transcript
sequence, to be very large proteins of 1579 and 1845 amino acids
in length, respectively, and prokaryotic expression of full-length
versions of these two proteins was unsuccessful. To overcome
expression difficulties, the CDS for Deg-HGP-1 and Deg-VIT-1 were
divided into two sections (N-terminal and C-terminal domains).
Production of recombinant 6xHis-tagged Deg-HGP-1 N- and C-
terminal domains and Deg-VIT-1 N-terminal domain was
successful.
3.5. Assessment of the acaricidal potential of the recombinant vaccine
candidates
Hens were injected three times with 50 lg of the recombinant
vaccine candidates formulated with 200 lg of QuilA in order to
generate serum-IgY responses. The generation and longevity ofthe immune response was monitored using Western blotting and
ELISA which showed that hens generated an antigen-specific and
sustained IgY response encompassing the period when the mite
feeding assays were performed (data not shown). Mites fed on
the blood from hens immunised with Deg-SRP-1, Deg-PUF-1 and
Deg-VIT-1 were 2.09 (95% CI: 1.48, 2.94), 2.79 (95% CI: 2.01,
3.88) and 2.03 (95% CI: 1.66, 2.48) times more likely to die during
the 96 h following feeding than mites fed on blood from hens
immunised with adjuvant only (P < 0.001, Table 3). The majority
of mite mortality occurred within 24 h after feeding on immunised
blood (Fig. 7). For example, mites fed on blood from hens immu-
nised with groups Deg-SRP-1, Deg-PUF-1 and Deg-VIT-1 recorded
mean mortality rates as 0.24 (95% CI: 0.12, 0.41), 0.29 (95% CI:
0.16, 0.48) and 0.50 (95% CI: 0.37, 0.64) at 24 h post feeding; these
estimates were statistically significantly (P < 0.040) higher than the
corresponding control groups at that time point. The mean mortal-
ity rate of Deg-HGP-1 group was 0.47 (95% CI: 0.33, 0.61) at 24 h
post feeding, and there was weak evidence (P < 0.052) that the esti-
mate was higher compared with the control group at that time
point.4. Discussion
The work described herein has demonstrated, to our knowledge
for the first time, the use of a combined immunological, proteomic
and genomic approach to vaccine candidate discovery for the poul-
try red mite. To complement these methodologies, the resulting
candidate molecules were expressed as recombinant proteins
and tested for vaccine efficacy in vitro, resulting in the identifica-
tion of three key vaccine candidate molecules with vaccine efficacy
similar to native mite extracts (cf. Tables 2 and 3).
All D. gallinae motile stages (larva, protonymph, deuteronymph
and adult), except larva, are haematophagous (Kirkwood, 1968),
and as such, all motile stages, except larva, are potentially suscep-
tible to the effects of ingested antibodies present in the blood of
vaccinated hens. Therefore we did not selectively target vaccine
identification to a specific development stage and instead under-
took a mixed-stage approach, which allowed the opportunity of
immunoreactive proteins present in the protective SME, regardless
of stage or gender bias, to be identified.
Traditional vaccinology has relied upon a pragmatic approach
to vaccine candidate identification, where extracts of native pro-
teins are repeatedly subfractionated using column-based protein
separation technologies and tested in vivo for immunogenicity
Table 5
Identification of Dermanyssus gallinae proteins present in IgY-immunoreactive spots on a two-dimensional gel immunoblot of the soluble mite extract fractionated by ion
exchange chromatography (IEX group 4). Those contigs selected for evaluation as vaccine candidates are given in bold.
D. gallinae
contig
number
2-DGE
immuno-
blot
Immuno-
affinity
enrichment
Top BLASTx hit description and (species) NCBI accession of
top BLASTx hit
%
identity
E value Bit
score
contig00171
p p
Vitellogenin 2 (Neoseiulus cucumeris) AGQ56699.1 55.3 0 751.5
contig00200
p
Heat shock protein, putative (Ixodes scapularis) XP_002407132.1 82.0 0 990.7
contig00293
p
PREDICTED: lysosomal aspartic protease-like (Metaseiulus
occidentalis)
XP_003738999.1 68.4 7.29E154 550.8
contig00394
p p
PREDICTED: uncharacterized protein LOC100906494
(Metaseiulus occidentalis)
XP_003742265.1 52.8 0 2631.6
contig00411
p
PREDICTED: elongation factor 2-like (Metaseiulus
occidentalis)
XP_003744110.1 91.7 0 1558.5
contig00472
p
Heat shock protein 60 (Neoseiulus cucumeris) AGQ50608.1 89.6 0 989.2
contig01288
p
PREDICTED: eukaryotic initiation factor 4A-II-like
(Metaseiulus occidentalis)
XP_003740341.1 86.5 0 657.9
contig01715
p
PREDICTED: alpha-aminoadipic semialdehyde synthase,
mitochondrial-like (Metaseiulus occidentalis)
XP_003743993.1 87.8 3.23E132 477.2
contig02408
p
PREDICTED: V-type proton ATPase subunit B-like
(Metaseiulus occidentalis)
XP_003739895.1 96.1 2.27E172 395.2
contig03001
p
PREDICTED: uncharacterized protein LOC100906494
(Metaseiulus occidentalis)
XP_003742265.1 52.4 1.85E80 305.8
contig03511
p
PREDICTED: GTP-binding nuclear protein Ran-like
(Metaseiulus occidentalis)
XP_003738953.1 86.4 6.05E81 305.4
contig04115
p
PREDICTED: 78 kDa glucose-regulated protein-like isoform 2
(Metaseiulus occidentalis)
XP_003743478.1 79.9 2.17E54 219.2
contig04550
p
PREDICTED: alpha-aminoadipic semialdehyde synthase,
mitochondrial-like (Metaseiulus occidentalis)
XP_003743993.1 85.7 9.61E31 86.7
contig04596
p
PREDICTED: glutamate dehydrogenase, mitochondrial-like
(Metaseiulus occidentalis)
XP_003737714.1 96.9 5.61E98 209.1
contig08052
p
PREDICTED: isocitrate dehydrogenase [NAD] subunit
gamma, mitochondrial-like (Metaseiulus occidentalis)
XP_003738563.1 90.0 3.71E30 136.7
contig08304
p
PREDICTED: alpha-aminoadipic semialdehyde synthase,
mitochondrial-like (Metaseiulus occidentalis)
XP_003743993.1 80.8 3.44E57 128.3
contig08760
p
PREDICTED: glutathione reductase-like (Metaseiulus
occidentalis)
XP_003748614.1 71.0 2.60E15 87.4
contig11091
p
PREDICTED: 78 kDa glucose-regulated protein-like isoform 2
(Metaseiulus occidentalis)
XP_003743478.1 94.9 3.55E153 373.6
contig11504
p
Probable ATP-dependent RNA helicase DDX6 (Strongyloides
ratti)
CEF64374.1 63.5 8.94E153 492.7
contig11553
p
MULTISPECIES: ABC transporter substrate-binding protein
(Brucella)
WP_008936495.1 32.4 0.0448883 45.1
contig11846
p p
PREDICTED: uncharacterized protein LOC100898154
(Metaseiulus occidentalis)
XP_003738142.1 47.3 6.04E64 250.8
contig11864
p
PREDICTED: glycine N-methyltransferase-like (Metaseiulus
occidentalis)
XP_003739110.1 77.0 1.00E166 481.0
contig11897
p p
Vitellogenin 2 (Neoseiulus cucumeris) AGQ56699.1 61.5 0 1466.8
contig12013
p p
Vitellogenin 1 (Varroa destructor) AFN88463.1 60.5 0 2327.4
contig12143
p
PREDICTED: heat shock 70 kDa protein cognate 4-like
(Metaseiulus occidentalis)
XP_003746930.1 78.5 0 664.8
contig12579
p
PREDICTED: uncharacterized protein LOC100898154
(Metaseiulus occidentalis)
XP_003738142.1 43.3 8.65E57 226.5
contig13080
p
PREDICTED: actin-5C-like (Metaseiulus occidentalis) XP_003742602.1 98.1 0 748.0
contig13089
p p
PREDICTED: uncharacterized protein LOC100898154
(Metaseiulus occidentalis)
XP_003738142.1 43.9 9.90E65 253.4
contig13090
p
PREDICTED: actin, cytoplasmic 2-like isoform 2 (Metaseiulus
occidentalis)
XP_003736979.1 99.1 1.16E55 221.5
contig13094
p
PREDICTED: uncharacterized protein LOC100900885
(Metaseiulus occidentalis)
XP_003745143.1 73.2 0 764.2
contig13207
p p
Large lipid transfer protein (Varroa destructor) AGW50714.1 42.7 0 356.7
contig13301
p
Actin 3 (Neoseiulus cucumeris) AGQ50606.1 97.8 7.63E76 288.5
contig13306
p
PREDICTED: glutamine synthetase 1, mitochondrial-like
(Metaseiulus occidentalis)
XP_003747444.1 84.0 0 339.7
contig13317
p p
Vitellogenin 2 (Neoseiulus cucumeris) AGQ56699.1 60.0 0 1870.5
contig13348
p
PREDICTED: ATP synthase subunit beta, mitochondrial-like
isoform 1 (Metaseiulus occidentalis)
XP_003745616.1 83.6 0 831.2
2-DGE, two-dimensional gel electrophoresis.
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testing, complex mixtures of proteins can be distiled down into
fractions containing relatively pure preparations of protective pro-
tein(s). The pragmatic approach was instrumental for the identifi-
cation of the Bm86 antigen, which is the protective component of
the Rhipicephalus microplus TickGard vaccine (Willadsen et al.,1988, 1989; Willadsen, 2004) and in the identification of the
multi-subunit Haemonchus galactose-containing glycoprotein
(H-gal-GP) vaccine (Smith et al., 1994, 1999). In recent years, a
dramatic increase in publically available proteomic, genomic and
transcriptomic data has enabled an in silico approach to be used
for vaccine discovery for many pathogens species, with antigen
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Fig. 5. Two-dimensional gel and immunoblot analyses of the pooled ion exchange chromatograph fractions (IEX groups 1 and 4) derived from Dermanyssus gallinae soluble
mite extracts. (A–C) IEX group 1; (D–F) IEX group 4 proteins were separated on replicate gels with pI ranges of 7–11 (IEX group 1) and 3–10 (IEX group 4). Two replicate gels
were electroblotted and screened with yolk-IgY from hens vaccinated three times with their respective IEX group 1 or 4 proteins (A and D, respectively) or with yolk-IgY from
group 7 hens that had been immunised with adjuvant only (B and E). Bound IgY was detected with rabbit anti-IgY-peroxidase IgG and visualised with chemiluminescent
substrate. A third gel replicate of IEX groups 1 and 4 (C and F) was stained with SimplyBlueTM SafeStain (Thermo Fisher Scientific) and the corresponding locations of the
immuno-reactive spots and were identified and excised from the gel for liquid chromatography–electrospray ionisation–tandemmass spectrometry (LC–ESI–MS/MS) (circled
and numbered).
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sub-cellular location, transmembrane domains and epitope
prediction (Goodswen et al., 2015). Whilst a quicker and cheaper
alternative to the pragmatic approach, in silico antigen discovery
is reliant on accurate data and precludes antigen selection based
on in vivo immunogenicity, and must therefore involve additional
in vivo screening at a later stage. By combining the pragmatic
approach with newer ‘omic’ technologies, the immunogenicity
component of the pragmatic approach can be retained whilst
maximising antigen identification by searching peptide data
(generated from vaccine candidate proteins using mass
spectrometry technologies) against high coverage ‘omic’ datasets.
This combined strategy has been successfully applied to vaccine
antigen identification for several ecto- and endo-parasite species
(Smith et al., 2009; De la Fuente and Merino, 2013; McNulty
et al., 2014) and herein with D. gallinae.
While 2-D immunoblotting has previously been widely used to
identify vaccine candidate antigens in parasite species (e.g. Nisbet
et al., 2010) this technique necessarily requires that proteins are
exposed to chaotropic conditions i.e. urea, thiourea and CHAPS in
the first (IEF) dimension, and subsequently to a powerful anionic
surfactant i.e. SDS, in the second. The ensuing protein denaturation
is likely to result in an underestimation of the numbers of
immunoreactive proteins actually present in the sample, especially
where antibody-based recognition is reliant upon the preservation
of conformational epitopes. With this caveat in mind, a comple-
mentary non-denaturing immunoaffinity approach was used toenrich proteins whilst preserving their native globular conforma-
tion, as proposed by Ellis et al. (2014), leading to an enhanced iden-
tification of vaccine candidates from IEX group 4 (Table 5). The
identities of more than two-thirds of the resulting vaccine candi-
dates from both IEX groups 1 and 4 were informed by their homol-
ogy to proteins of the western orchard predatory mite, Metaseiulus
occidentalis (Acari: Phytoseiidae), reflecting the availability of
annotated genomic data for this species (http://www.ncbi.nlm.
nih.gov/bioproject/62309). In spite of the generation of large tran-
scriptomic datasets for D. gallinae (Bartley et al., 2012; Schicht
et al., 2013, 2014), a full annotated genome for D. gallinae remains
a priority together with the relevant tools to investigate gene func-
tion in this species to inform the targeting of novel interventions
and control methodologies (Marr et al., 2014; Viney, 2014). These
tools would be of particular relevance to understanding the nature
of Deg-PUF-1, a protein of unknown function shown here to be a
strong vaccine candidate.
Immunoreactive candidate proteins (Tables 4 and 5) were
selected for further evaluation in immunisation experiments using
a rational order of merit based on intensity of immune recognition;
likelihood of exposure of the antigen to the antibodies in a blood
meal (Willadsen, 2004); proposed function and known vaccine
potential of orthologous molecules. Mitochondrial enzymes were
excluded from consideration as vaccine candidate molecules
because, although many were highly immunogenic, they were
unlikely to be exposed to host antibody following immunisation.
Two proteolytic enzymes, Deg-ASP-1 and Deg-CPR-1, were
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Fig. 6. Immunoaffinity enrichment of Dermanyssus gallinae proteins using
immobilised antigen-specific IgY. Yolk-IgY generated against ion exchange chro-
matography group 4 proteins was cross-linked to a HiTrap N-hydroxysuccinimide
(NHS)-activated column and IEX group 4 proteins were selectively bound to the
column, washed to remove unbound material and then eluted into an affinity
enriched fraction with 0.1 M Glycine, 6 M Urea, pH 2.5. (A) The IEX group 4 proteins
prior to affinity purification (lanes 1 and 3) and the eluted affinity-enriched
material (lanes 2 and 4) were separated on a 12% Bis–Tris Novex gel (GE Healthcare)
and transferred to nitrocellulose. Lanes 1 and 2 of the immunoblot were probed
with a 1:200 dilution of sera from naive hens that had not been immunised with the
soluble mite extract and lanes 3 and 4 were probed with a 1:200 dilution of post-
vaccination sera from hens immunised with IEX group 4. Bound IgY was detected
with rabbit anti-IgY-peroxidase (Sigma) and visualised using SIGMA FASTTM 3,30-
diaminobenzidine substrate (Sigma). (B) The eluted immunoaffinity enriched IEX
group 4 material was concentrated fivefold by lyophilisation and 30 ll was
electrophoretically separated as before and stained with SimplyBlueTM SafeStain
(lane 5). The gel lane was sectioned into 24 equally-sized horizontal slices and the
proteins extracted and subjected to liquid chromatography–electrospray ionisa-
tion–tandem mass spectrometry (LC–ESI–MS/MS).
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Fig. 7. The observed mean survival proportions of Dermanyssus gallinae following the
Immunisation of hens with the 10 recombinant vaccine candidates and subsequent m
heparinised blood from hens immunised with the tranche 1 recombinant vaccine candid
Deg-VIT-1, Deg-PUF-3, Deg-SRP-2, Deg-CPR-1) or with adjuvant only (control). The feedi
mites at 24, 48, 72 and 96 h post-feeding, with corresponding 95% confidence intervals (
plotted.
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mite mortalities following feeding on hens immunised with these
molecules were not as consistent as those measured previously
when using different D. gallinae aspartyl and cysteine proteinases
as immunogens (Bartley et al., 2012).
As a result of their profound effects on blood coagulation,
homeostasis, fibrinolysis, complement activation and immune
effector regulation; serine proteinase inhibitors (serpins) have
been advocated as vaccine candidate proteins in a range of
blood-borne (e.g. Brugia malayi, Zang et al., 1999) and haematopha-
gous pathogens including other members of the Acari (e.g. in the
metastriate tick Amblyomma americanum, Mulenga et al., 2001;
Porter et al., 2015). Here, immunisation of hens with the serpin
Deg-SRP-1 resulted in a significantly increased (>twofold) chance
of mortality in mites feeding on blood from the immunised hens
compared with those feeding on blood from hens immunised with
adjuvant alone (Table 3). This effect was not universal to all ser-
pins, however, as immunisation with Deg-SRP-2 did not produce
the same effects, suggesting distinct biological roles and/or locali-
sation of these two molecules in D. gallinae.
After traversing the gut epithelium, host serum immunoglobu-
lins are capable of entering the haemolymph of haematophagous
arthropods and interacting with components of the haemolymph
(e.g. vitellogenin) and the membrane receptors involved in pro-
cesses such as receptor-mediated endocytosis during the incorpo-
ration of vitellogenin by developing oocytes (Sauer et al., 1994).
This has led to the investigation of vitellogenin and vitellogenin-
like molecules (e.g. hemelipoglycoprotein, Donohue et al., 2008)
as vaccine candidate molecules in haematophagous arthropods
and informed our selection of Deg-VIT-1 and Deg-HGP-1 for vac-
cine efficacy testing. Previously, immunisation of sheep with puri-
fied vitellin (the mature form of vitellogenin) from the tick R.
microplus resulted in significantly reduced numbers of engorged
ticks with decreased weights and reduced oviposition following 
eeding (h) 
0 48 72 24 96 0 48 72 24 96 0 48 72 24 96 
Deg-SRP-2 Deg-CPR-1 Control 
 0 48 72 24 96 0 48 72 24 96 0 48 72 24 96 
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e 
ingestion of blood from hens immunised with recombinant vaccine candidates.
ite feeding assays were performed in two tranches. Mites were fed with whole
ates (A: Deg-ASP-1, Deg-GPD-1, Deg-SRP-1, Deg-PUF-1) or tranche 2 (B: Deg-HGP-1,
ng assays were performed in three replicates and the mean proportions of surviving
shaded) calculated using Cox’s proportional hazard model with frailty function, are
K. Bartley et al. / International Journal for Parasitology 45 (2015) 819–830 829challenge (Tellam et al., 2002). We have demonstrated that host
IgY is able to enter the haemolymph of D. gallinae following a blood
meal from hens (Nisbet et al., 2006). Vitellogenin and hemelipogly-
coprotein are therefore accessible to vaccine-induced antibodies
following a blood meal on an immunised host, and both Deg-VIT-
1 and Deg-HGP-1 induced significant levels of mite mortality when
used as immunogens (Table 3). Given the physiological role of
vitellogenins in oocyte maturation as well as other functions in
arthropods (Morandin et al., 2014), a further benefit of immunisa-
tion of hens with D. gallinae vitellogenins may be reduced produc-
tion or viability of mite eggs, leading to delayed expansion of mite
populations in hen houses. Although vitellogenin and hemelipogly-
coprotein share many conserved functional domains including a
lipoprotein N-terminal domain (heme, lipid and carbohydrate
binding) and the von-Willebrand factor type D, their pattern of
expression differs in haematophagous arthropods. For example,
hemelipoglycoprotein in the tick Dermacentor variabilis is, unlike
vitellogenin, expressed in life stages other than mated females
(Thompson et al., 2007; Donohue et al., 2008) and is therefore
indicative of functions unrelated to oocyte maturation. Hemelipo-
glycoprotein is undoubtedly multifunctional and is involved in the
sequestering of free heme (Maya-Monteiro et al., 2000) and poten-
tially in protection from heme-induced radical damage (Maya-
Monteiro et al., 2004). In addition, hemeolipoglycoprotein has been
proposed to play a role in innate immunity in ticks (Dupejova et al.,
2011; Sterba et al., 2011).
In conclusion, we have demonstrated an integrated methodol-
ogy for the identification of vaccine candidate molecules from D.
gallinae and tested the potential of these molecules in vitro. The
ability of the selected vaccine antigens to control mite populations
in commercial poultry facilities must now be demonstrated and
this requires formulation of the antigens in appropriate adjuvant
and delivery vehicles for sustained antibody responses in the host.
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